These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

525 related items for PubMed ID: 10077171

  • 1. Stability of cutaneous anergy in women with or at risk for HIV infection. HIV Epidemiology Research Study Group.
    Klein RS, Sobel J, Flanigan T, Smith D, Margolick JB.
    J Acquir Immune Defic Syndr Hum Retrovirol; 1999 Mar 01; 20(3):238-44. PubMed ID: 10077171
    [Abstract] [Full Text] [Related]

  • 2. Instability of delayed-type hypersensitivity skin test anergy in human immunodeficiency virus infection.
    Caiaffa WT, Graham NM, Galai N, Rizzo RT, Nelson KE, Vlahov D.
    Arch Intern Med; 1995 Oct 23; 155(19):2111-7. PubMed ID: 7575072
    [Abstract] [Full Text] [Related]

  • 3. The effect of immunodeficiency on cutaneous delayed-type hypersensitivity testing in HIV-infected women without anergy: implications for tuberculin testing. HER Study Group. HIV Epidemiology Research.
    Klein RS, Flanigan T, Schuman P, Smith D, Vlahov D.
    Int J Tuberc Lung Dis; 1999 Aug 23; 3(8):681-8. PubMed ID: 10460100
    [Abstract] [Full Text] [Related]

  • 4. Prevalence of and risk factors for tuberculin positivity and skin test anergy in HIV-1-infected and uninfected at-risk women. Women's Interagency HIV Study (WIHS).
    Anastos K, Kalish LA, Palacio H, Benson CA, Delapenha R, Chirgwin K, Stonis L, Telzak EE.
    J Acquir Immune Defic Syndr; 1999 Jun 01; 21(2):141-7. PubMed ID: 10360806
    [Abstract] [Full Text] [Related]

  • 5. Criteria for assessing cutaneous anergy in women with or at risk for HIV infection. HIV Epidemiologic Research Study Group.
    Klein RS, Flanigan T, Schuman P, Smith D, Vlahov D.
    J Allergy Clin Immunol; 1999 Jan 01; 103(1 Pt 1):93-8. PubMed ID: 9893191
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Delayed-type hypersensitivity (DTH) test anergy does not impact CD4 reconstitution or normalization of DTH responses during antiretroviral therapy.
    Minidis NM, Mesner O, Agan BK, Okulicz JF.
    J Int AIDS Soc; 2014 Jan 01; 17(1):18799. PubMed ID: 24499779
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Delayed-type hypersensitivity anergy in human immunodeficiency virus-infected persons screened for infection with Mycobacterium tuberculosis.
    Huebner RE, Schein MF, Hall CA, Barnes SA.
    Clin Infect Dis; 1994 Jul 01; 19(1):26-32. PubMed ID: 7948554
    [Abstract] [Full Text] [Related]

  • 13. Risk for developing tuberculosis among anergic patients infected with HIV.
    Moreno S, Baraia-Etxaburu J, Bouza E, Parras F, Pérez-Tascón M, Miralles P, Vicente T, Alberdi JC, Cosín J, López-Gay D.
    Ann Intern Med; 1993 Aug 01; 119(3):194-8. PubMed ID: 8100693
    [Abstract] [Full Text] [Related]

  • 14. Prevalence of tuberculin positivity and skin test anergy in HIV-1-seropositive and -seronegative intravenous drug users.
    Graham NM, Nelson KE, Solomon L, Bonds M, Rizzo RT, Scavotto J, Astemborski J, Vlahov D.
    JAMA; 1992 Jan 15; 267(3):369-73. PubMed ID: 1727959
    [Abstract] [Full Text] [Related]

  • 15. Purified protein derivative tuberculin and delayed-type hypersensitivity skin testing in migrant farm workers at risk for tuberculosis and HIV coinfection.
    Villarino ME, Geiter LJ, Schulte JM, Castro KG.
    AIDS; 1994 Apr 15; 8(4):477-81. PubMed ID: 8011250
    [Abstract] [Full Text] [Related]

  • 16. The incidence of tuberculosis in drug users with small tuberculin reaction sizes.
    Klein RS, Gourevitch MN, Teeter R, Schoenbaum EE.
    Int J Tuberc Lung Dis; 2001 Aug 15; 5(8):707-11. PubMed ID: 11495260
    [Abstract] [Full Text] [Related]

  • 17. The prevalence of anergy in human immunodeficiency virus-infected adolescents and the association of delayed-type hypersensitivity with subject characteristics.
    Smith Rogers A, Ellenberg JH, Douglas SD, Henry-Reid L, Peralta L, Wilson CM.
    J Adolesc Health; 2000 Dec 15; 27(6):384-90. PubMed ID: 11090740
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Cutaneous anergy in pregnant and nonpregnant women with human immunodeficiency virus.
    Eriksen NL, Helfgott AW.
    Infect Dis Obstet Gynecol; 1998 Dec 15; 6(1):13-7. PubMed ID: 9678142
    [Abstract] [Full Text] [Related]

  • 20. Reliability of anergy skin testing in persons with HIV infection. The pulmonary Complications of HIV Infection Study Group.
    Chin DP, Osmond D, Page-Shafer K, Glassroth J, Rosen MJ, Reichman LB, Kvale PA, Wallace JM, Poole WK, Hopewell PC.
    Am J Respir Crit Care Med; 1996 Jun 15; 153(6 Pt 1):1982-4. PubMed ID: 8665065
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 27.